<DOC>
	<DOCNO>NCT00009711</DOCNO>
	<brief_summary>RATIONALE : Assessing long-term effect bone marrow transplant lung function patient may improve ability plan treatment . PURPOSE : This clinical trial study lung function pediatric patient undergone bone marrow transplant .</brief_summary>
	<brief_title>Study Lung Function Children Who Have Undergone Bone Marrow Transplantation</brief_title>
	<detailed_description>OBJECTIVES : - Determine delayed effect bone marrow transplantation preparative regimen pulmonary function child survive least 5 year transplantation hematologic malignancy . - Determine relationship pulmonary function growth rate patient . - Determine effect growth hormone treatment pulmonary function patient . - Determine relationship pulmonary function age time transplantation patient . - Determine incidence severity restrictive pulmonary disease , whether factor vary increase time transplantation patient . OUTLINE : Patients undergo respiratory history , sign symptom assessment , pulmonary function test ( PFT ) include spirometry , lung volume , diffusion , oxygen saturation pulse oximetry , height measurement . Patients assess 5-10 year , 10-15 year , 15 year bone marrow transplantation . Patients abnormal PFTs assess frequent interval clinically indicate . PROJECTED ACCRUAL : Approximately 280 patient accrue study .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Patients undergo bone marrow transplantation hematologic malignancy least 5 year ago Diseasefree survivor least 6 year age AND Under 18 year age time transplantation Received prior allogeneic , unrelated donor , syngeneic , autologous bone marrow transplantation Able perform pulmonary function test PATIENT CHARACTERISTICS : Age : See Disease Characteristics Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : See Disease Characteristics Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : Any prior preparative regimen allow</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>pulmonary complication</keyword>
</DOC>